Corporate Banner
Satellite Banner
Biomolecular Screening
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Redd&Whyte Appoints HighRes Biosolutions as New US Distributor

Published: Thursday, February 28, 2013
Last Updated: Thursday, February 28, 2013
Bookmark and Share
Appointment offers US scientists specialist access to its unique liquid handling technology.

Redd&Whyte, an expert supplier of liquid handling automation for drug discovery and life science research applications, today announced it has appointed HighRes Biosolutions, a leading developer of flexible laboratory automation systems, as US distributor for its Preddator low-volume microplate dispensers. The appointment will provide US researchers with rapid access to, and support of, unique technology for achieving consistent results and reducing assay costs, by dispensing low-volumes of difficult reagents into microplates.

Under the terms of the agreement, HighRes Biosolutions will market Redd&Whyte’s Preddator range in North America. The versatile Preddator, which can dispense viscous liquids including gels, cell suspensions and DMSO in any microplate format from 96-3456 wells, will be integrated into HighRes’ patented MicroDock technology. This will allow scientists to easily add and remove the Preddator from HighRes’ automated assay preparation and screening systems.

Redd&Whyte chose HighRes to market its equipment in North America because the firm is respected for its modular design of versatile laboratory automation and specialist knowledge of integrating state-of-the-art liquid handlers into their systems. HighRes also has a large network of life science specialists across the USA, who will provide further information on integrated solutions that include the Preddator system.

Roger Poole, Managing Director of Redd&Whyte commented: "Recently, we have had great success in the North American market with our Preddator system and are delighted to have HighRes Biosolutions as our new distribution partner to support this growth.”

Poole added: “HighRes is a first-rate company, with an excellent reputation for its versatile approach to integrating only the best low-volume liquid handlers into their systems. Our unique, flexible low-volume microplate dispensing technology will perfectly complement the products HighRes provides so we’re excited to have them offering Preddator as part of their portfolio.”


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,400+ scientific posters on ePosters
  • More than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Preddator Low-volume Microplate Dispenser Awarded ELRIG Prize
Recognizing technology’s novel method of improving liquid handling efficiency.
Wednesday, July 10, 2013
Redd&Whyte Appoints New UK Sales Manager
Appointment to provide professional service and support for UK scientists.
Thursday, February 21, 2013
Redd&Whyte Appoints New Director of Business Development
Appointment of Rob Harkness as part of new growth strategy.
Thursday, August 23, 2012
Redd&Whyte wins Best New Company at the Life Science Awards
Redd&Whyte was awarded Best New Company at the inaugural Life Science Awards, on 29 June in Hamburg, Germany, preceding the first European Lab Automation conference and exhibition.
Thursday, July 07, 2011
Scientific News
Liquid Biopsies: Utilization of Circulating Biomarkers for Minimally Invasive Diagnostics Development
Market Trends in Biofluid-based Liquid Biopsies: Deploying Circulating Biomarkers in the Clinic. Enal Razvi, Ph.D., Managing Director, Select Biosciences, Inc.
Lab-on-a-Chip Offers Promise for TB and Asthma Patients
A device to mix liquids using ultrasonics is the first and most difficult component in a miniaturized system for low-cost analysis of sputum from patients with pulmonary diseases such as tuberculosis and asthma.
Protein Related to Long Term Traumatic Brain Injury Complications Discovered
NIH-study shows protein found at higher levels in military members who have suffered multiple TBIs.
Urine Proteins Point to Early-Stage Pancreatic Cancer
A combination of three proteins found at high levels in urine can accurately detect early-stage pancreatic cancer, researchers at the BCI have shown.
Researcher Discovers Trigger of Deadly Melanoma
New research sheds light on the precise trigger that causes melanoma cancer cells to transform from non-invasive cells to invasive killer agents, pinpointing the precise place in the process where "traveling" cancer turns lethal.
Crystal Clear Images Uncover Secrets of Hormone Receptors
NIH researchers gain better understanding of how neuropeptide hormones trigger chemical reactions in cells.
New Tool Uses 'Drug Spillover' to Match Cancer Patients with Treatments
Researchers have developed a new tool that improves the ability to match drugs to disease: the Kinase Addiction Ranker (KAR) predicts what genetics are truly driving the cancer in any population of cells and chooses the best "kinase inhibitor" to silence these dangerous genetic causes of disease.
HIV Susceptibility Linked to Little-Understood Immune Cell Class
High levels of diversity among immune cells called natural killer cells may strongly predispose people to infection by HIV, and may be driven by prior viral exposures, according to a new study.
Sweet Revenge Against Superbugs
A special type of synthetic sugar could be the latest weapon in the fight against superbugs.
Access Denied: Leukemia Thwarted by Cutting Off Link to Environmental Support
A new study reveals a protein’s critical – and previously unknown -- role in the development and progression of acute myeloid leukemia (AML), a fast-growing and extremely difficult-to-treat blood cancer.
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,400+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!